Patients with fatal outcomes presented increased levels of interferon-λ, TGF-α, thymic stromal lymphopoietin (TSLP), IL-16, IL-23, and IL-33, and markers linked to coagulopathy, such as thrombopoietin [81]. This evidence concerns the gene TSLP and blood coagulation disease.